Salt-wasting congenital adrenal hyperplasia: genotypical peculiarities in a Sicilian ethnic group.
Here we report for the first time the results of the molecular study of 17 unrelated patients with salt-wasting (SW) congenital adrenal hyperplasia (CAH) belonging to a Sicilian ethnic group, as corroborated by patients' pedigree taken to include 2 generations in the paternal and maternal lineage. The aim of this report was to confirm that genetic basis of CAH may be characterized by population differences. In our series, the overall predominant mutation was IVS2A/C>G, that was detected in 50% of alleles and in 58.8% of patients. The allelic and homozygous frequencies of IVS2A/C>G, Del8bpE3, and R356W mutations were significantly higher in our series than in other populations. Our study population included 2 cases with 2 different mutations that have been recently reported for the first time, 3 cases with a double mutation on the same allele, and 1 case with homozygous de novo mutation. We concluded that: a) in a Sicilian ethnic group the most frequent genotype in SW CAH is IVS2A/C>G homozygocity; b) surprisingly Del8bpE3 and R256W homozygocity are also well represented.
Wasniewska
M
M
Department of Pediatrics, University of Messina, Messina, Italy. wasniewska@yahoo.it
Caruso
M
M
Indovina
S
S
Crisafulli
G
G
Mirabelli
S
S
Salzano
G
G
Arrigo
T
T
De Luca
F
F
D000312:Adrenal Hyperplasia, Congenital / Q000097:blood / Q000208:ethnology / Q000235:genetics*; D004252:DNA Mutational Analysis; D005006:Ethnicity / Q000235:genetics*; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D008297:Male; D010641:Phenotype; D017354:Point Mutation; D012802:Sicily; D012964:Sodium / Q000097:blood*; D017673:Sodium Chloride, Dietary; D013255:Steroid 21-Hydroxylase / Q000235:genetics*
D017673:Sodium Chloride, Dietary; D012964:Sodium; C531510:CYP21A2 protein, human; D013255:Steroid 21-Hydroxylase
Clin Endocrinol (Oxf). 2000 Jul;53(1):117-25
10931088
J Med Genet. 1998 Dec;35(12):1014-9
9863599
Mol Genet Metab. 2007 Apr;90(4):414-21
17275379
Eur J Endocrinol. 2005 Jul;153(1):99-106
15994751
Horm Res. 2005;63(3):119-24
15775714
J Endocrinol Invest. 2005 Dec;28(11):1038-9
16483186
J Clin Endocrinol Metab. 2001 Jun;86(6):2845-8
11397897
Hum Genet. 1996 Aug;98(2):182-4
8698338
J Clin Endocrinol Metab. 2005 Oct;90(10):5769-73
16046588
J Clin Endocrinol Metab. 2004 Jan;89(1):368-74
14715874
J Clin Endocrinol Metab. 1995 Aug;80(8):2322-9
7629224
J Endocrinol Invest. 2007 Mar;30(3):181-5
17505149
J Endocrinol Invest. 2007 Oct;30(9):806-7
17993777
J Clin Endocrinol Metab. 2000 Mar;85(3):1059-65
10720040
J Clin Endocrinol Metab. 2003 Aug;88(8):3852-9
12915679
J Clin Endocrinol Metab. 2006 Nov;91(11):4510-3
16912133
J Clin Endocrinol Metab. 2004 May;89(5):2402-7
15126570
J Clin Endocrinol Metab. 2003 Jun;88(6):2624-33
12788866
Endocr Rev. 2000 Jun;21(3):245-91
10857554